These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 14565284)

  • 1. 2-Phenylhydroxypropynyladenosine derivatives as high potent agonists at A2B adenosine receptor subtype.
    Lambertucci C; Volpini R; Costanzi S; Taffi S; Vittori S; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):809-12. PubMed ID: 14565284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
    Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
    Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.
    de Zwart M; Kourounakis A; Kooijman H; Spek AL; Link R; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1384-92. PubMed ID: 10212124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
    J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Saponaro G; Baraldi S; Romagnoli R; Moorman AR; Gessi S; Varani K; Borea PA
    Bioorg Med Chem; 2007 Apr; 15(7):2514-27. PubMed ID: 17306548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
    Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
    J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
    J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
    Volpini R; Camaioni E; Costanzi S; Vittori S; Klotz KN; Cristalli G
    Nucleosides Nucleotides; 1999; 18(11-12):2511-20. PubMed ID: 10639752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.
    Ashton TD; Baker SP; Hutchinson SA; Scammells PJ
    Bioorg Med Chem; 2008 Feb; 16(4):1861-73. PubMed ID: 18042389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
    Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
    J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
    Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
    J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine.
    Lambertucci C; Costanzi S; Vittori S; Volpini R; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1153-7. PubMed ID: 11562976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.